FDA panel considers antipsychotic drugs for children

06/10/2009 | Reuters

An FDA panel is considering whether three major antipsychotic drugs should be advertised as approved for use in children and teens with schizophrenia or bipolar disorder. Eli Lilly and Co.'s Zyprexa, AstraZeneca's Seroquel and Pfizer's Geodon are approved for adults and used in children, but the companies need the FDA's approval to advertise them for use in younger patients. FDA reviewers concede the medications work but want to consider side effects, such as weight gain and sleepiness, before deciding.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC